Simple view

Full metadata view

Authors

Statistics

Ibrutinib versus temsirolimus : 3-year follow-up of patients with previously treated mantle cell lymphoma from the phase 3, international, randomized, open-label RAY study

2018
journal article
article
10.1038/s41375-018-0023-2
Journal
Leukemia
45
Author
Rule S.

Jurczak Wojciech

Jerkeman M.

Rusconi C.

Trneny M.
Show more
Volume
32
Number
8
Pages
1799-1803
ISSN
0887-6924
eISSN
1476-5551
Language
English
Journal language
English
Affiliation
Wydział Lekarski : Klinika Hematologii
Scopus© citations
86
cris.lastimport.wos2024-04-09T19:10:01Z
dc.affiliationWydział Lekarski : Klinika Hematologiipl
dc.cm.date2020-01-07
dc.cm.id88559
dc.contributor.authorRule, S.pl
dc.contributor.authorJurczak, Wojciech - 129923 pl
dc.contributor.authorJerkeman, M.pl
dc.contributor.authorRusconi, C.pl
dc.contributor.authorTrneny, M.pl
dc.contributor.authorOffner, F.pl
dc.contributor.authorCaballero, D.pl
dc.contributor.authorJoao, C.pl
dc.contributor.authorWitzens-Harig, M.pl
dc.contributor.authorHess, G.pl
dc.contributor.authorBence-Bruckler, I.pl
dc.contributor.authorCho, S.-G.pl
dc.contributor.authorThieblemont, C.pl
dc.contributor.authorZhou, W.pl
dc.contributor.authorHenninger, T.pl
dc.contributor.authorGoldberg, J.pl
dc.contributor.authorVermeulen, J.pl
dc.contributor.authorDreyling, M.pl
dc.date.accessioned2020-01-17T09:58:42Z
dc.date.available2020-01-17T09:58:42Z
dc.date.issued2018pl
dc.date.openaccess0
dc.description.accesstimew momencie opublikowania
dc.description.number8pl
dc.description.physical1799-1803pl
dc.description.points45pl
dc.description.versionostateczna wersja wydawcy
dc.description.volume32pl
dc.identifier.doi10.1038/s41375-018-0023-2pl
dc.identifier.eissn1476-5551pl
dc.identifier.issn0887-6924pl
dc.identifier.projectROD UJ / OPpl
dc.identifier.urihttps://ruj.uj.edu.pl/xmlui/handle/item/143126
dc.languageengpl
dc.language.containerengpl
dc.rightsUdzielam licencji. Uznanie autorstwa 4.0 Międzynarodowa*
dc.rights.licenceCC-BY
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/legalcode.pl*
dc.share.typeinne
dc.subtypeArticlepl
dc.titleIbrutinib versus temsirolimus : 3-year follow-up of patients with previously treated mantle cell lymphoma from the phase 3, international, randomized, open-label RAY studypl
dc.title.journalLeukemiapl
dc.typeJournalArticlepl
dspace.entity.typePublication
cris.lastimport.wos
2024-04-09T19:10:01Z
dc.affiliationpl
Wydział Lekarski : Klinika Hematologii
dc.cm.date
2020-01-07
dc.cm.id
88559
dc.contributor.authorpl
Rule, S.
dc.contributor.authorpl
Jurczak, Wojciech - 129923
dc.contributor.authorpl
Jerkeman, M.
dc.contributor.authorpl
Rusconi, C.
dc.contributor.authorpl
Trneny, M.
dc.contributor.authorpl
Offner, F.
dc.contributor.authorpl
Caballero, D.
dc.contributor.authorpl
Joao, C.
dc.contributor.authorpl
Witzens-Harig, M.
dc.contributor.authorpl
Hess, G.
dc.contributor.authorpl
Bence-Bruckler, I.
dc.contributor.authorpl
Cho, S.-G.
dc.contributor.authorpl
Thieblemont, C.
dc.contributor.authorpl
Zhou, W.
dc.contributor.authorpl
Henninger, T.
dc.contributor.authorpl
Goldberg, J.
dc.contributor.authorpl
Vermeulen, J.
dc.contributor.authorpl
Dreyling, M.
dc.date.accessioned
2020-01-17T09:58:42Z
dc.date.available
2020-01-17T09:58:42Z
dc.date.issuedpl
2018
dc.date.openaccess
0
dc.description.accesstime
w momencie opublikowania
dc.description.numberpl
8
dc.description.physicalpl
1799-1803
dc.description.pointspl
45
dc.description.version
ostateczna wersja wydawcy
dc.description.volumepl
32
dc.identifier.doipl
10.1038/s41375-018-0023-2
dc.identifier.eissnpl
1476-5551
dc.identifier.issnpl
0887-6924
dc.identifier.projectpl
ROD UJ / OP
dc.identifier.uri
https://ruj.uj.edu.pl/xmlui/handle/item/143126
dc.languagepl
eng
dc.language.containerpl
eng
dc.rights*
Udzielam licencji. Uznanie autorstwa 4.0 Międzynarodowa
dc.rights.licence
CC-BY
dc.rights.uri*
http://creativecommons.org/licenses/by/4.0/legalcode.pl
dc.share.type
inne
dc.subtypepl
Article
dc.titlepl
Ibrutinib versus temsirolimus : 3-year follow-up of patients with previously treated mantle cell lymphoma from the phase 3, international, randomized, open-label RAY study
dc.title.journalpl
Leukemia
dc.typepl
JournalArticle
dspace.entity.type
Publication
Affiliations
Wydział Lekarski
Jurczak, Wojciech
No affiliation
Rule, S.
Jerkeman, M.
Rusconi, C.
Trneny, M.
Offner, F.
Caballero, D.
Joao, C.
Witzens-Harig, M.
Hess, G.
Bence-Bruckler, I.
Cho, S.-G.
Thieblemont, C.
Zhou, W.
Henninger, T.
Goldberg, J.
Vermeulen, J.
Dreyling, M.

* The migration of download and view statistics prior to the date of April 8, 2024 is in progress.

Views
11
Views per month
Views per city
Ashburn
3
Des Moines
2
Wroclaw
2
Dublin
1
Downloads
jurczak_et-al_ibrutinib_versus_temsirolimus_3-year_follow-up_2018.odt
8
jurczak_et-al_ibrutinib_versus_temsirolimus_3-year_follow-up_2018.pdf
5

Open Access

Thumbnail Image
License
CC-BY

Except as otherwise noted, this item is licensed under : Udzielam licencji. Uznanie autorstwa 4.0 Międzynarodowa

Collections
Research publications
Medical sciences
Publications of the Medical College
ROD UJ